Carole Tirapo

发表

Contribution of CDKN2A/P16INK4A, P14ARF, CDK4 and BRCA1/2 germline mutations in individuals with suspected genetic predisposition to uveal melanoma

L. Desjardins, D. Stoppa-Lyonnet, C. Houdayer, 2010, Familial Cancer.

Ploidy and large-scale genomic instability consistently identify basal-like breast carcinomas with BRCA1/2 inactivation.

A. Vincent-Salomon, O. Delattre, M. Bollet, 2012, Cancer research.

Integrated Systems and Technologies Ploidy and Large-Scale Genomic Instability Consistently Identify Basal-like Breast Carcinomas with BRCA 1 / 2 Inactivation

O. Delattre, M. Bollet, C. Houdayer, 2012 .

Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriers

Peter Devilee, Alfons Meindl, Lesley McGuffog, 2010, Breast Cancer Research.

Germline mutation in the RAD51B gene confers predisposition to breast cancer

A. Nicolas, M. Stern, D. Stoppa-Lyonnet, 2013, BMC Cancer.

Comparison of mRNA splicing assay protocols across multiple laboratories: recommendations for best practice in standardized clinical testing.

F. Couch, A. Spurdle, M. Southey, 2014, Clinical chemistry.

Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study

V. Pankratz, F. Couch, B. Bonanni, 2012, British Journal of Cancer.

Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers.

Christiana Kartsonaki, Mads Thomassen, Etienne Rouleau, 2011, Human molecular genetics.

EMMA, a cost‐ and time‐effective diagnostic method for simultaneous detection of point mutations and large‐scale genomic rearrangements: application to BRCA1 and BRCA2 in 1,525 patients

D. Stoppa-Lyonnet, C. Houdayer, J. Viovy, 2011, Human mutation.

Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers.

V. Pankratz, F. Couch, T. Rebbeck, 2011, Human molecular genetics.

Comparison of mRNA splicing assay protocols across multiple laboratories: recommendations for best practice in standardized clinical testing.

F. Couch, A. Spurdle, M. Southey, 2014, Clinical chemistry.